14:10:16 EDT Thu 29 Oct 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
MustGrow Biologics Corp.
Symbol MGRO
Shares Issued 70,441,359
Close 2026-10-28 C$ 0.38
Market Cap C$ 26,767,716
Recent Sedar+ Documents

ORIGINAL: Market One Minute Feature on BNN Bloomberg: MustGrow Biologics and Bayer AG Discusses Validation of Its TerraMG Biocontrol Technology

2026-10-29 12:55 ET - News Release

Vancouver, British Columbia--(Newsfile Corp. - October 29, 2026) - Market One ("Market One"), a marketing agency for public companies, shares editorial and video features on emerging growth stories across the resource, energy, and technology sectors.

Market One delivers content creation and distribution through a suite of products across video, editorial, and social media.

MustGrow Biologics Corp.: Advancing Its TerraMG™ Biocontrol Partnership with Bayer AG

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") and Bayer AG discuss their License and Collaboration agreement covering Europe, the Middle East, and Africa, including field trials confirming TerraMG™'s control of soil-borne diseases, its compatibility with European application equipment, and receipt of a first milestone payment.

The article and accompanying video examines how Bayer's nearly two-year evaluation and subsequent agreement are advancing MustGrow's mustard-derived biocontrol technology, against the backdrop of tightening European regulation on synthetic pesticides and fertilizers and growing demand for biological crop inputs.



Cannot view this video? Visit:
https://www.youtube.com/watch?v=R7m7VUmZYAo

To read the full article, please visit BNN Bloomberg at: https://www.bnnbloomberg.ca/investment-trends/2026/10/29/mustgrow-and-bayer-advance-mustard-based-biocontrol-in-europe-the-middle-east-and-africa/

About MustGrow Biologics Corp.

MustGrow Biologics is a Saskatchewan-based agriculture biotechnology company commercializing mustard seed-derived biological solutions — including TerraMG™ soil biocontrol and TerraSante™ biofertility — backed by approximately 110 issued and pending patents. The company pursues a capital-efficient licensing model, partnering with global crop science leaders such as Bayer, which holds exclusive rights across Europe, the Middle East, and Africa under an agreement valued at approximately USD $35-40 million before royalties and manufacturing sales.

Learn more at mustgrow.ca.
Follow MustGrow Biologics on LinkedIn, Facebook, X, and YouTube.

Contact:
Corey Giasson, Director & CEO
Phone: 1-306-668-2652
Email: info@mustgrow.ca

About Market One

Market One is a Canadian marketing agency for public companies, delivering best-in-class content creation and distribution. The firm helps position companies for meaningful engagement through a suite of products across video, editorial, and social media. Clients benefit from increased visibility and strengthened awareness through Market One's content and relationships with industry-leading media outlets.

Learn more at marketone.ca.

Contact:
Bryan Nikkel
Phone: 778-836-0109
Email: bryan@marketone.ca

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321626

© 2026 Canjex Publishing Ltd. All rights reserved.